Par Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Par Pharmaceuticals's estimated annual revenue is currently $405.8M per year.
- Par Pharmaceuticals's estimated revenue per employee is $201,000
- Par Pharmaceuticals has 2019 Employees.
- Par Pharmaceuticals grew their employee count by -1% last year.
Par Pharmaceuticals Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Par Pharmaceuticals?
Pharmaceutical Resources, Inc. (PRI) is a holding company that, through its subsidiaries, is in the business of developing, manufacturing and distributing a broad line of generic drugs in the United States. PRI operates primarily through its wholly owned subsidiary, Par Pharmaceutical, Inc., a manufacturer and distributor of generic drugs. The Company's product line consists of prescription and, to a lesser extent, over-the-counter generic drugs consisting of approximately 119 products representing various dosage strengths for 51 drugs. In addition to manufacturing its own products, the Company has strategic alliances with several pharmaceutical and chemical companies providing it with products for sale through distribution, development or licensing agreements. The Company markets its products primarily to wholesalers, retail drug store chains, drug distributors and repackagers.keywords:N/A
Number of Employees
Employee Growth %
Par Pharmaceuticals News
He also worked for Novartis Consumer Health, Par Pharmaceutical, ... Most recently, he worked for Zoetis Pharmaceuticals in Charles City,...
Par Pharmaceutical, Pfizer, Novartis, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals.
... Prospects till 2028 | Par Pharmaceutical, Pfizer Inc., Eagle Pharmaceuticals, Inc., Astellas Pharma Inc., Cumberland Pharmaceuticals Inc.
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|